NOS2 and Alzheimer disease: Besides increasing the hippocampal contents of 5-HT3 and ACh, the tested agents skewed M1 microglia to the protective M2 phenotype confirmed by the increased IL-4 and the decreased NOS2-mediated Aβ nitration, besides activating IDE to facilitate the clearance of Aβ and to halt AD progression.